Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Emptoz-Bonneton A"'
Autor:
Ghina Alameh, Agnès Emptoz-Bonneton, Marc Rolland de Ravel, Eva L. Matera, Elisabeth Mappus, Patrick Balaguer, Luc Rocheblave, Thierry Lomberget, Charles Dumontet, Marc Le Borgne, Michel Pugeat, Catherine Grenot, Claude Y. Cuilleron
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 684-691 (2019)
Synthetic progesterone and 5α/β-pregnane-3,20-dione derivatives were evaluated as in vitro and in vivo modulators of multidrug-resistance (MDR) using two P-gp-expressing human cell lines, the non-steroidogenic K562/R7 erythroleukaemia cells and the
Externí odkaz:
https://doaj.org/article/55b0290ee7904a11adb07838554e6862
Autor:
Alameh, Ghina1 (AUTHOR), Emptoz-Bonneton, Agnès1,2 (AUTHOR), Rolland de Ravel, Marc1,3 (AUTHOR), Matera, Eva L.3 (AUTHOR), Mappus, Elisabeth1 (AUTHOR), Balaguer, Patrick4 (AUTHOR), Rocheblave, Luc1,5 (AUTHOR), Lomberget, Thierry1,5 (AUTHOR), Dumontet, Charles3 (AUTHOR), Le Borgne, Marc5 (AUTHOR) marc.le-borgne@univ-lyon1.fr, Pugeat, Michel1,2 (AUTHOR), Grenot, Catherine1 (AUTHOR), Cuilleron, Claude Y.1 (AUTHOR) yves.cuilleron@inserm.fr
Publikováno v:
Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2019, Vol. 34 Issue 1, p684-691. 8p.
Autor:
Luc Rocheblave, Thierry Lomberget, Patrick Balaguer, Charles Dumontet, Eva Laure Matera, Catherine Grenot, Claude Y Cuilleron, Ghina Alameh, E Mappus, Agnès Emptoz-Bonneton, Michel Pugeat, Marc Rolland de Ravel, Marc Le Borgne
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2019, 34 (1), pp.684-691. ⟨10.1080/14756366.2019.1575825⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, 2019, 34 (1), pp.684-691. ⟨10.1080/14756366.2019.1575825⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 684-691 (2019)
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2019, 34 (1), pp.684-691. ⟨10.1080/14756366.2019.1575825⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, 2019, 34 (1), pp.684-691. ⟨10.1080/14756366.2019.1575825⟩
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 684-691 (2019)
International audience; Synthetic progesterone and 5α/β-pregnane-3,20-dione derivatives were evaluated as in vitro and in vivo modulators of multidrug-resistance (MDR) using two P-gp-expressing human cell lines, the non-steroidogenic K562/R7 erythr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f99c031fa0528de7af7dd78aa823532
https://hal.archives-ouvertes.fr/hal-02077612/document
https://hal.archives-ouvertes.fr/hal-02077612/document
Autor:
Sonia Beltran, Nadia Walchshofer, Marc Le Borgne, Roland Barret, Agnès Emptoz-Bonneton, Charles Dumontet, Michel Pugeat, Catherine Grenot, Zahia Mahiout, Maxime Melikian, Eva-Laure Matera, Lucienne El Jawad, Ghina Alameh, Elisabeth Mappus, Luc Rocheblave, Marc Rolland de Ravel, Claude Yves Cuilleron, Thierry Lomberget
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (4), pp.1832-1845. ⟨10.1021/jm501676v⟩
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (4), pp.1832-1845. ⟨10.1021/jm501676v⟩
A simple route for improving the potency of progesterone as a modulator of P-gp-mediated multidrug resistance was established by esterification or etherification of hydroxylated 5α/β-pregnane-3,20-dione or 5β-cholan-3-one precursors. X-ray crystal
Autor:
Nathalie Iannuccelli, Patrick Chardon, Denis Milan, Olga Ousova, Pierre Mormède, Martine Yerle, Véronique Guyonnet-Dupérat, Jean Pierre Bidanel, Marie-Pierre Moisan, Agnès Emptoz-Bonneton, C Genêt, Bastien Llamas, Joël Gellin, Michel Pugeat
Publikováno v:
Molecular Endocrinology 7 (18), 1687-1696. (2004)
Molecular Endocrinology-Baltimore
Molecular Endocrinology-Baltimore-, Endocrine Society, In press, 18 (7), pp.1687-1696
HAL
Molecular Endocrinology-Baltimore-, 2004, 18 (7), pp.1687-1696. ⟨10.1210/me.2004-0005⟩
Molecular Endocrinology-Baltimore
Molecular Endocrinology-Baltimore-, Endocrine Society, In press, 18 (7), pp.1687-1696
HAL
Molecular Endocrinology-Baltimore-, 2004, 18 (7), pp.1687-1696. ⟨10.1210/me.2004-0005⟩
We present data suggesting that corticosteroid-binding globulin (CBG) may be the causal gene of a previously identified quantitative trait locus (QTL) associated with cortisol levels, fat, and muscle content in a pig intercross. Because Cbg in human
Autor:
Hervé Lejeune, Patrice Cousin, Gérald Raverot, Laurence Calemard-Michel, Agnès Emptoz-Bonneton, Nadia Yessaad, Yves Morel, Michel Pugeat
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 89:917-924
SHBG is the specific plasma transport protein for sex steroid hormones in humans. Plasma SHBG concentration follows a gender dimorphism but varies with nutritional and hormonal status in both sexes. In addition, a genetic influence on SHBG in humans
Autor:
Chantal Bully, Patrice Cousin, George V. Avvakumov, Koji Seguchi, Geoffrey L. Hammond, Agnès Emptoz-Bonneton, Michel Pugeat
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:361-367
Corticosteroid-binding globulin (CBG) is the plasma transport protein that regulates the access of glucocorticoid hormones to target cells. Genetic deficiencies of CBG are rare, and only a single human CBG variant (Trancortin Leuven) has been related
Publikováno v:
Critical Care Medicine. 26:452-460
To analyze the effect of low-fat nutritional solutions, with or without fish oil, on serum interleukin (IL)-6, and to explore the relationships between IL-6, corticosteroid-binding globulin (CBG; the main cortisol carrier in plasma), and protein meta
Autor:
A. Emptoz-Bonneton
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 82:3758-3762
Autor:
François Larivière, Agnès Emptoz-Bonneton, Nazem Naman, Nathalte Jobin, Michel Pugeat, Mohammad Razi, Dominique R. Garrel
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 19:482-491
The optimal amount and type of fat in the nutrition support of burned patients have not been determined. The aim of this study was to test low-fat nutritional solutions, with or without fish oil, on protein metabolism, morbidity, and length of care i